» Articles » PMID: 29055623

Targeting of Cell Surface Proteolysis of Collagen XVII Impedes Squamous Cell Carcinoma Progression

Abstract

Squamous cell carcinoma (SCC) is one of the most common skin cancers and causes significant morbidity. Although the expression of the epithelial adhesion molecule collagen XVII (ColXVII) has been linked to SCC invasion, only little is known about its mechanistic contribution. Here, we demonstrate that ColXVII expression is essential for SCC cell proliferation and motility. Moreover, it revealed that particularly the post-translational modification of ColXVII by ectodomain shedding is the major driver of SCC progression, because ectodomain-selective immunostaining was mainly localized at the invasive front of human cutaneous SCCs, and exclusive expression of a non-sheddable ColXVII mutant in SCC-25 cells inhibits their matrix-independent growth and invasiveness. This cell surface proteolysis, which is strongly elevated during SCC invasion and metastasis, releases soluble ectodomains and membrane-anchored endodomains. Both released ColXVII domains play distinct roles in tumor progression: the endodomain induces proliferation and survival, whereas the ectodomain accelerates invasiveness. Furthermore, specific blockage of shedding by monoclonal ColXVII antibodies repressed matrix-independent growth and invasion of SCC cells in organotypic co-cultures. Thus, selective inhibition of ColXVII shedding may offer a promising therapeutic strategy to prevent SCC progression.

Citing Articles

Biological implications of decoding the extracellular matrix of vulva cancer.

Islam M, Debnath K, Moniruzzaman R, Okuyama K, Islam S, Dongre H Oncol Rep. 2024; 53(2).

PMID: 39670289 PMC: 11652961. DOI: 10.3892/or.2024.8852.


Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer.

Crespo-Bravo M, Thorlacius-Ussing J, Nissen N, Pedersen R, Boisen M, Liljefors M BMC Cancer. 2023; 23(1):949.

PMID: 37803411 PMC: 10557271. DOI: 10.1186/s12885-023-11470-5.


Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.

Kavasi R, Neagu M, Constantin C, Munteanu A, Surcel M, Tsatsakis A Front Med (Lausanne). 2022; 9:879500.

PMID: 35572966 PMC: 9100789. DOI: 10.3389/fmed.2022.879500.


BP180/Collagen XVII: A Molecular View.

Tuusa J, Kokkonen N, Tasanen K Int J Mol Sci. 2021; 22(22).

PMID: 34830116 PMC: 8623354. DOI: 10.3390/ijms222212233.


The Role of Collagen XVII in Cancer: Squamous Cell Carcinoma and Beyond.

Jones V, Patel P, Gibson F, Cordova A, Amber K Front Oncol. 2020; 10:352.

PMID: 32266137 PMC: 7096347. DOI: 10.3389/fonc.2020.00352.


References
1.
Streit M, Velasco P, Brown L, Skobe M, Richard L, Riccardi L . Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol. 1999; 155(2):441-52. PMC: 1866855. DOI: 10.1016/S0002-9440(10)65140-1. View

2.
Nykvist P, Tasanen K, Viitasalo T, Kapyla J, Jokinen J, Bruckner-Tuderman L . The cell adhesion domain of type XVII collagen promotes integrin-mediated cell spreading by a novel mechanism. J Biol Chem. 2001; 276(42):38673-9. DOI: 10.1074/jbc.M102589200. View

3.
Giannelli G, Astigiano S, Antonaci S, Morini M, Barbieri O, Noonan D . Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasion. Clin Exp Metastasis. 2002; 19(3):217-23. DOI: 10.1023/a:1015579204607. View

4.
Franzke C, Tasanen K, Schacke H, Zhou Z, Tryggvason K, Mauch C . Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J. 2002; 21(19):5026-35. PMC: 129053. DOI: 10.1093/emboj/cdf532. View

5.
Parikka M, Kainulainen T, Tasanen K, Vaananen A, Bruckner-Tuderman L, Salo T . Alterations of collagen XVII expression during transformation of oral epithelium to dysplasia and carcinoma. J Histochem Cytochem. 2003; 51(7):921-9. DOI: 10.1177/002215540305100707. View